NU
Nuvation Bio Inc.
NUVB-WT · NYSE
$0.07 -0.89% (-$0.00)
Market Cap $23.0M
P/E Ratio -
Div. Yield -
ROE 49.73%
Bulios Fair Price
$0.08
19.2% upside
Current Price
$0.067
Undervalued Fair Value Overvalued
According to Bulios Fair Price, NUVB-WT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.14x
P/B 0.09x
P/E N/A
Growth
0 /100
Declining Book val. growth 22.43%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 93.94%
FCF margin 48.69%
Net margin 88.19%
Quality
3 /100
Poor ROIC 20.68%
Asset turnover 0.23x
ROE 49.73%
Debt
46 /100
Moderate Debt/Equity 0.99x
Int. coverage -4.84x
Current ratio 8.37x
Stability
1 /100
Unstable Beta 2.05x
Profitable years 0
EPS volatility 319.58%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about NUVB-WT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David Hung
Employees
72
Headquarters
New York